The industrialization of additive manufacturing of metals

Process optimization and improved output with ZEISS microscopes Customer Story Until recently, additive manufacturing (AM) was thought to have value solely in prototyping new products or designs. Today, however, it is evolving into a game changing production technology. From medical implants to aircraft turbines – there is a wide range of potential applications for industrial 3D printed... Read more

Brooks Automation Announces 2018 Analyst and Investor Day

CHELMSFORD, Mass., May 7, 2018 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS), a leading worldwide provider of automated and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences, announced today that it will host its 2018 Analyst and Investor Day on Tuesday, May 22, 2018 in New York City. The conference will feature... Read more

Thermo Fisher Scientific to Host Analyst Meeting

WALTHAM, Mass., April 30, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will host its 2018 Analyst Meeting on Wednesday, May 23, starting at 9:00 a.m. (ET), at the Mandarin Oriental New York, 80 Columbus Circle at 60th Street, in New York City. The meeting... Read more

CHMP recommends EU approval of Roche’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence

Basel, 27 April 2018 CHMP recommends EU approval of Roche’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence In the large phase III APHINITY study, the combination of Perjeta, Herceptin and chemotherapy significantly reduced the risk of invasive breast cancer recurrence or death by 19% compared to Herceptin and... Read more

CHMP recommends EU approval of Roche’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence

Basel, 27 April 2018 CHMP recommends EU approval of Roche’s Perjeta for post-surgery treatment of HER2-positive early breast cancer at high risk of recurrence In the large phase III APHINITY study, the combination of Perjeta, Herceptin and chemotherapy significantly reduced the risk of invasive breast cancer recurrence or death by 19% compared to Herceptin and... Read more

Be part of it: Global Summit on Best Practices in Preanalytics

The Global Summit for Best Practices in Preanalytics is back! The conference will be held October 15-18 at the Embassy Suites Ayrsley Hotel and Convention Center in Charlotte, North Carolina (USA). This event should not be missed by staff in the medical industry as well as phlebotomists! The Preanalytics Global Summit for Best Practices is... Read more

Official Opening of the APAC Support Center in Shanghai

Supporting customers in the Asia-Pacific region News The opening of the ZEISS Microscopy APAC Support Center (ASC) in Shanghai is another milestone for ZEISS Microscopy to enable and support customers in the increasingly important and growing APAC region. “We can only ensure sustainable growth if we’re in a position to deliver the services our customers... Read more

Thermo Fisher Scientific Highlights Digital Science Innovations at Analytica 2018

MUNICH, April 10, 2018 /PRNewswire/ — Analytica 2018 — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled an expanded portfolio of new instruments and software designed to accelerate discovery and enhance productivity for customers working in pharma and biotech, environmental analysis, academic research and other applications. Digital science highlights on display... Read more

ZEISS delivers tomographic imaging with results 4x faster for geologists & geological industries

Iterative reconstruction with ZEISS OptiRecon News The new module for the ZEISS Xradia Versa 500-series of 3D X-ray microscopes (XRM) will allow users to acquire high quality images in one-quarter the time: ZEISS OptiRecon uses a new, advanced iterative reconstruction technique. Now you can make the optimal choice for your requirements: same quality images four... Read more

Neue Vereinbarungen unterstreichen QIAGENs führende Rolle in der Bioinformatik

HILDEN, Deutschland und AARHUS, Dänemark, February 2, 2016 /PRNewswire/ — Zentren und Wissenschaftler der FDA erhalten Zugang zu QIAGENs umfangreichen Lösungen für Anwendungen in der mikrobiellen und metagenomischen Analyse sowie anderen Bereichen  QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) hat heute bekannt gegeben, dass das Unternehmen neue Partnerschaften eingegangen ist, um das Profil seiner... Read more